Preview

Biocon

Good Essays
Open Document
Open Document
673 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Biocon
BIOCON 1. Assuming Biocon receives approval for BioMab, should it launch the drug immediately or conduct phase 3 trials before launch? Elaborate on the various elements of your action plan. 2. How big is the current and future market opportunity in BIOMAb?
The current market opportunity of BIOMAb is limited but the future is going to be bigger. In 2004, the 5-year prevalence (number of people diagnosed with cancer and still alive after 5 years) was 375,000 and the incidence (new cases per year) was 132,000 for head and neck cancer in India. However, only 1% percent of the Indian population can afford the drug. According to Biocon estimates in 2007, the market potential for BIOMAb in head and neck cancer based on incidence and % affordability was 1,900 patients new cases per year.
The market opportunity will be bigger in India because of the country’s improving economy (9% yearly) and increasing population (1.4% population growth rate). BIOMAb can also be marketed abroad and the international incidence is at least 7-8X that in India. BIOMAb may also be approved for other indications such as for colorectal cancer. The incidence rate for colorectal cancer in India in 2004 was 33,000 but internationally it was 1,023,000 and the 5-yr prevalence 2,830,000.
However, BIOMAb has a competitor in the international arena, Erbitux, which had been approved by US FDA for colorectal cancer in 2004 and introduced in India in April 2006 for colorectal cancer. 3. Who is the buyer for BIOMAb? What is the decision making unit in this case? What are the benefits that each member of the decision making unit seeks from BIOMAb?
???The buyers for BIOMAb are the oncology doctors who will make the decisions and recommendations to their patients as to what treatment their patients will receive. The decision making unit is…….
The benefits that each member of the decision making unit seeks include BIOMAb effectiveness in the treatment of cancer, affordability

You May Also Find These Documents Helpful

  • Good Essays

    Ethical Dillemmas

    • 538 Words
    • 3 Pages

    Decision making is a process of choosing the best alternative to achieve individual and organizational objectives. Identifying and using the decision-making process helps healthcare professionals at all levels to make more effective decisions. The acronym “DECIDE” helps aid through the most effective decision making process used by healthcare professionals at all levels. This model is an acronym of 6 particular activities needed in the decision-making process: (1) D = define the problem, (2) E = establish the criteria, (3) C = consider all the alternatives, (4) I = identify the best alternative, (5) D = develop and implement a plan of action, and (6) E = evaluate and monitor the solution and feedback when necessary.…

    • 538 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    hshjaxikz

    • 643 Words
    • 4 Pages

    4.4 Support the individual to make an informed decision about their preferred option and the associated risks…

    • 643 Words
    • 4 Pages
    Satisfactory Essays
  • Good Essays

    Medical Home

    • 823 Words
    • 4 Pages

    * Patients are to be included in their treatment plan and information technology must be utilized to ensure optimum patient care.…

    • 823 Words
    • 4 Pages
    Good Essays
  • Satisfactory Essays

    Cetuximab Case Study

    • 316 Words
    • 2 Pages

    Generally, patent biologics are in the cleft of expiration and there are a rise in the demand for biosimilar. Our company will start to develop biosimilar for Cetuximab (Erbitux), which is an epidermal growth factor receptor (EGFR) inhibitor. Eli Lilly produces the drug in the U.S and Canada market whereas Merm KGaA produced Cetuximab for territory outside the USA and Canada. We want to pursue a biosimilar for Cetuximab to build a brand image and find finance to move to our main focus, which is biosimilar for Blinatumomab. Blinatumomab (Blincyto) is a bifunctional antibody that used to treat Philadelphia chromosome-negative refractory acute lymphoblastic leukemia. Blinatumomab approved in December 2014 by the US Food and Drug Administration under the accelerated approval program.…

    • 316 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    It is a market blank now. If Biopure launch now, the company can race to control the blood substitutes market • The product is stable under a wide range temperature S W…

    • 906 Words
    • 14 Pages
    Satisfactory Essays
  • Good Essays

    Pharmaceutical companies often have relevant compounds that have not been assessed for their potential to treat colorectal cancer. The overall objective for this company, Arias Pharmaceuticals, is to help and support the discovery of new drug leads for colorectal cancer through networks and partnerships between pharmaceutical companies as well as academia. Specifically, the…

    • 1870 Words
    • 8 Pages
    Good Essays
  • Satisfactory Essays

    Find an option that would be best suited for Pharma to meet current and future demand.…

    • 717 Words
    • 3 Pages
    Satisfactory Essays
  • Better Essays

    Gmo Lab Report

    • 2784 Words
    • 12 Pages

    Sylvia R. M. Broeders, Sigrid C. J. De Keersmaecker, and Nancy H. C. Roosen. "How to Deal with the Upcoming Challenges in." Journal of Biomedicine and Biotechnolog (2012): 11.…

    • 2784 Words
    • 12 Pages
    Better Essays
  • Better Essays

    Decision Making In Nursing

    • 1052 Words
    • 5 Pages

    Decision making is used in the medical profession every day. Physicians are making decisions with every patient they see. The patient is also having to make the decision of what treatment to receive. Decision making is used during medical procedures. When making a decision one has to think of the best and productive treatment for the patient. Interviewing Marie Cain gave a lot of insight on her decision making with her lung cancer. Having a positive outlook on health, treatment, and prognosis can help a person through their progress. (Editor, page 5). Doctors are not the only decision makers, medical and office personnel in the office have decision making power also.…

    • 1052 Words
    • 5 Pages
    Better Essays
  • Powerful Essays

    In April 2000, the biopharmaceutical company Abgenix faced the important strategic decision of how to most profitably commercialize its XenoMouse based high potential cancer product ABX-EGF, which had reached phase I clinical trials after having successfully passed preclinicals.…

    • 1627 Words
    • 7 Pages
    Powerful Essays
  • Satisfactory Essays

    Biopure needs to determine the best course of action to launch two new products, Oxyglobin a blood substitute for the veterinary market and Hemopure a blood substitute for the human market. Oxyglobin has been approved for commercial use and is ready for launch while Hemopure is expected to be FDA approved within two years. Biopure needs to decide whether and when to launch Oxyglobin. If decided to launch, the ability to price Oxyglobin appropriately is critical to minimize the impact of prospective launch for Hemopure. We believe Oxyglobin should be launched immediately because…

    • 1016 Words
    • 5 Pages
    Satisfactory Essays
  • Good Essays

    Chris Wark

    • 649 Words
    • 3 Pages

    Colorectal tumor takes on the 2nd place for the world’s well-known cancer. Next to to the therapeutic treatment for this type of cancer, researchers have found another treatment which is more useful.…

    • 649 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    The health care industry Provides health products and service which involved the leading technology of life science. It is a fast-growing industry and will continue to grow in the future because of the increasing request to the advanced medical care. The Global Industry Analysis (GIA,2009) predicted that the prescription drug market is value around $897 billion in world economy in 2015, and Asia-Pacific region is expected to have highest growth in prescription drugs.…

    • 1121 Words
    • 5 Pages
    Powerful Essays
  • Satisfactory Essays

    Even though researchers are figuring out the concept of how these cancers are forming, Mukherjee stated that there is still a vast gap of knowledge about these diseases. Not to mention, the rigorous rift in drug development and the human testing, clinical trials that follows, production, etc. presents a chain of difficulties. What makes matter worse, the funding for the nation’s leading cancer research institute…

    • 233 Words
    • 1 Page
    Satisfactory Essays
  • Good Essays

    Merck Essay

    • 695 Words
    • 3 Pages

    Rejecting this investigation could have had a serious impact on the morale of Merck employees, who are "inspired to think of their work as a quest to alleviate human disease and suffering world-wide". Along the same lines, the approval for the 3 stages of clinical trials was also a decision based on Merck's overall corporate philosophy. A possible way in which the situation could have been improved at this stage would have been to start exploring a strategic partnership with a third party international entity or government, in order to increase the likelihood of achieving a future deal that would allow Merck to recoup some of the funds invested in this project, if a viable medication was ever…

    • 695 Words
    • 3 Pages
    Good Essays

Related Topics